Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

921 recalls · Class II, newest first

Class II · Moderate risk

Zyprexa Intramuscular

cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.

Terminated cGMP deviation Eli Lilly & Company NDC 0002-7597-01 D-0720-2021

Recalls by year